COSM

Cosmos Health Inc · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website cosmosholdingsinc.com
Employees(FY) 102
ISIN US2214133058

Performance

-3.64%

1W

-4.78%

1M

-18.7%

3M

-39.47%

6M

-53.21%

YTD

-80.13%

1Y

Profile

Cosmos Health Inc. provides proprietary line of branded and generic pharmaceuticals, nutraceuticals, over-the-counter medications, cosmetics, nursery, health care and baby products, and medical devices. Its nutraceutical product portfolio includes Sky Premium Life and Mediterranation. The company serves wholesale pharmaceutical distributors and independent retail pharmacies. It operates in Greece, Germany, the United Kingdom, Italy, Denmark, Croatia, and Cyprus. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

Advanced Technical Analysis

Technical Analysis of COSM 2024-05-03

Overview:

In analyzing the technical indicators for COSM over the last 5 days, we will delve into the trends, momentum, volatility, and volume aspects to provide a comprehensive outlook on the possible stock price movement. By examining key indicators such as moving averages, MACD, RSI, Bollinger Bands, and OBV, we aim to offer valuable insights...

See more ...

Recent News & Updates

2024-04-29 21:42
Stock Market Crash Warning: Don't Get Caught Holding These 3 Healthcare Stocks(Investorplace)
2024-04-19 04:30
Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K(Accesswire)
2024-03-20 21:45
Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform(Accesswire)
2024-03-18 22:10
Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market(Accesswire)
2024-03-17 21:25
Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders(Accesswire)
2024-02-28 20:25
Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million(Accesswire)
2024-02-22 11:00
As Trading Frenzies Grip Penny Stocks, Criticism of Nasdaq Grows(Yahoo Finance)
2024-02-20 22:50
Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price(Accesswire)
2024-02-20 20:30
Taglich Brothers Initiates Coverage of Cosmos Health Inc.(Globenewswire)
2024-02-19 20:25
Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company(Accesswire)
2024-01-31 20:25
Taglich Brothers Initiates Coverage of Cosmos Health Inc.(Accesswire)
2024-01-23 00:05
Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market(Accesswire)
2024-01-17 20:25
Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio(Accesswire)
2023-12-26 20:27
Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023(Yahoo Finance)
2023-12-19 20:15
Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X(Accesswire)
2023-12-17 20:15
Cosmos Health Announces Open Market Stock Purchases by the CEO(Accesswire)
2023-12-07 23:45
Cosmos Health to Participate at Capital Links 'Invest in Greece' Forum in New York(Accesswire)
2023-12-06 20:35
Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers(Accesswire)
2023-11-30 21:25
Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product(Accesswire)
2023-11-20 20:00
Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share(Accesswire)
2023-10-10 21:35
Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders(Accesswire)
2023-10-04 20:30
COSMOS HEALTH CEO Issues Letter to Shareholders(Accesswire)
2023-09-26 22:30
Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company(Accesswire)
2023-09-25 23:00
Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market(Yahoo Finance)
2023-09-22 00:50
Cosmos Health Announces Relaunch of bio-bebe, its Proprietary Organic Infant Care & Nutrition Brand; Aims to Penetrate $103bn Global Baby Food Market(Yahoo Finance)
2023-09-19 23:50
Cosmos Health Announces Strategic Collaboration with C.A.PAPAELLINAS Group(Yahoo Finance)
2023-09-12 20:30
Cosmos Health Starts Stock Buyback Program(Yahoo Finance)
2023-09-12 20:00
BestGrowthStocks.com issues New Growth Report on Cosmos Health(Yahoo Finance)
2023-09-11 20:30
Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023(Yahoo Finance)
2023-08-14 19:00
Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04(Yahoo Finance)

Page 1 of 4

previousnext